Telomere trial will tell women their cellular age

Elissa Epel, PhD

A UCSF clinical trial on lifestyle and aging will be among the first in the world to inform patients on the length of their telomeres – the protective caps at the end of chromosomes that shortens with age and stress. The trial, which is enrolling 250 women between ages 50 and 65, was highlighted in a July 5 front page story in the San Francisco Chronicle. The story quoted Elissa Epel, PhD, an associate professor of psychiatry at UCSF who is one of the lead researchers on the study. Epel said the field of telomere research has moved to a critical threshold, in which researchers are now able to assess whether it can be used as a clinical measurement. Because telomere length helps assess cellular health, the test has been identified as a possible biomarker to reveal information about a person’s overall health. This study will help determine whether that is possible, and whether lifestyle changes actually have an impact on an individual’s telomere length.

San Francisco Chronicle story:

To enroll in the trial, call (415) 476-7634 or email [email protected]

Follow UCSF on Twitter

NID:  3 626 Content Type:  media_coverage_page field_primarytopics:  Public Health Inline Files:  Primary Term:  Public Health Areas:  Research News Center People:  Elissa Epel Organizations:  Department of Psychiatry